RT @sasurai_NS: A systematic review of Beta-blockers for preventing stroke recurrence A review of 2 RCTs which included 2193 stroke patien…
A systematic review of Beta-blockers for preventing stroke recurrence A review of 2 RCTs which included 2193 stroke patients. There was no statistical differences between Beta-blocker group and placebo in risks of stroke. #neurosurgery https://t.co/RhiR
βblockerの脳卒中再発予防効果を調べたレビュー ・2つのRCTで、2193人の脳卒中or TIA患者を登録 ・アテノロール5mg と プラセボ群で比較 結果 ・脳卒中再発率は2群で有意差なし ・副作用はアテノロール群で優位に高い βblocker使用には懐疑的 #脳外科 https://t.co/hn6Kqik2T9
@shimmyshakemn @SethN12 @gtconway3d @shimmyshakemn I wanted to tag you specifically but I’m not sure about the beta blocker. He was in the hospital last week (poss stroke or chest pain), https://t.co/LB5lGGxuOD From my knowledge, the stress can override th
RT @Saudi_Pharma: @Saudi_Pharma Beta-blockers for preventing stroke recurrence https://t.co/VFCCMaEICn
T1E2A2 No evidencia suficiente para uso #BetaBloqueantes en prevención 2ª de #ictus o AIT. Vía @ernestob http://t.co/65pjVupQlD
T1E2A2 No evidencia suficiente para uso #BetaBloqueantes en prevención 2ª de #ictus o AIT. Vía @ernestob http://t.co/65pjVupQlD
T1E2A2 No evidencia suficiente para uso #BetaBloqueantes en prevención 2ª de #ictus o AIT. Vía @ernestob http://t.co/65pjVupQlD
T1E2A2 No evidencia suficiente para uso #BetaBloqueantes en prevención 2ª de #ictus o AIT. Vía @ernestob http://t.co/65pjVupQlD
T1E2A2 No evidencia suficiente para uso #BetaBloqueantes en prevención 2ª de #ictus o AIT. Vía @ernestob http://t.co/65pjVupQlD
No available evidence supports the routine use of beta-blockers for secondary prevention after stroke/TIA [Cochrane] http://t.co/454iRHmndy
No available evidence supports the routine use of beta-blockers for secondary prevention after stroke/TIA [Cochrane] http://t.co/454iRHmndy
No available evidence supports the routine use of beta-blockers for secondary prevention after stroke/TIA [Cochrane] http://t.co/454iRHmndy
(Revisión)Sin evidencia que respalde el uso rutinario de betabloqueantes en prevención 2ª de ictus/AIT http://t.co/7X8cd1iRQk via @ernestob
No available evidence supports the routine use of beta-blockers for secondary prevention after stroke/TIA [Cochrane] http://t.co/454iRHmndy
(Revisión)Sin evidencia que respalde el uso rutinario de betabloqueantes en prevención 2ª de ictus/AIT http://t.co/7X8cd1iRQk via @ernestob
No available evidence supports the routine use of beta-blockers for secondary prevention after stroke/TIA [Cochrane] http://t.co/454iRHmndy
No available evidence supports the routine use of beta-blockers for secondary prevention after stroke/TIA [Cochrane] http://t.co/454iRHmndy
No available evidence supports the routine use of beta-blockers for secondary prevention after stroke/TIA [Cochrane] http://t.co/454iRHmndy
No available evidence supports the routine use of beta-blockers for secondary prevention after stroke/TIA [Cochrane] http://t.co/454iRHmndy
Beta-blockers for preventing stroke recurrence. [Cochrane Database Syst Rev. 2014] - PubMed - NCBI http://t.co/06dNrzN6z1